Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults
Clinical trial NCT03408899 · COMPLETED
Trial details
- NCT number
- NCT03408899
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2019-04-19
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.